caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1871532945

Mark ChanMD

Physical Medicine and RehabilitationOakland, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Mark Chan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
VISTA IMAGING SERVICES, INC98247
WEBSTER SURGERY CENTER, LP80186
SUTTER EAST BAY HOSPITALS79207
DUNN, MONTY66159
The Surgery Center Of Alta Bates Summit Medical Center, Llc
Ambulatory Surgical Center · Oakland, CA
3269
Mathias Masem
Orthopedic Surgery · Oakland, CA
1222
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
394
Unique beneficiaries
—
Total services
652
Distinct HCPCS
8
Medicare payment
$77K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 710 Physical Medicine and Rehabilitation providers in CA — below median (cohort median 1,331).
PRESCRIBING · PART D · 2024
Total Rx claims
528
Beneficiaries
—
Total drug cost
$7K
Distinct drugs
11
Brand share
34.3%
Top prescribed drugs
Gabapentin151 claims
Hydrocodone/Acetaminophen127 claims
Tramadol Hcl62 claims
Oxycodone Hcl/Acetaminophen40 claims
Meloxicam34 claims
QUALITY · MIPS · 2024
Final MIPS score
20.9
Quality
0.0
Cost
69.7
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-6.49%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.